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Abstract 
Coronary microvascular resistance is increasingly measured as a predictor of clinical outcomes, but 
there is no accepted gold-standard measurement. We compared the diagnostic accuracy of two 
invasive indices of microvascular resistance, Doppler-derived hyperemic microvascular resistance 
(hMR) and thermodilution-derived index of microcirculatory resistance (IMR), at predicting 
microvascular dysfunction. 54 patients (61±10 years) undergoing cardiac catheterization, for stable 
coronary artery disease (n=10) or acute myocardial infarction (AMI, n=44), had simultaneous 
intracoronary pressure, Doppler flow velocity and thermodilution flow data acquired from 74 
unobstructed vessels, at rest and hyperemia. Three independent measures of microvascular function 
were assessed, using predefined dichotomous thresholds: i) CFR, the average value of Doppler- and 
thermodilution-derived coronary flow reserve (CFR), and cardiovascular magnetic resonance derived: 
ii) Myocardial Perfusion Reserve Index (MPRI) and iii) Microvascular Obstruction (MVO). hMR 
correlated with IMR (rho = 0.41, p<0.0001). hMR had better diagnostic accuracy than IMR to predict 
CFR (area under curve, (AUC) 0.82 versus 0.58, p<0.001, sensitivity/specificity 77/77% versus 
51/71%) and MPRI (AUC 0.85 versus 0.72, p=0.19, sensitivity/specificity 82/80% versus 64/75%). In 
AMI patients, the AUCs of hMR and IMR at predicting extensive MVO were 0.83 and 0.72 
respectively (p=0.22, sensitivity/specificity 78/74% versus 44/91%). We measured two invasive 
indices of coronary microvascular resistance to predict multiple distinct measures of microvascular 
dysfunction. We found these two invasive indices only correlate modestly and so cannot be considered 
equivalent. In our study, the correlation between independent invasive and non-invasive measures of 
microvascular function was better with hMR than with IMR.  
 
Key words: Coronary microvascular resistance; myocardial infarction; hyperemic microvascular 
resistance (hMR); index of microcirculatory resistance (IMR)  
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Introduction 
Up to 50% of patients have microvascular obstruction (MVO) 
1
 post primary percutaneous coronary 
intervention (PPCI), resulting in worse clinical outcomes. 
2
 MVO reflects microvascular dysfunction 
(MVD) due to distal embolization of thrombus, endothelial dysfunction, reperfusion injury and 
intramyocardial hemorrhage.
3
 MVD also indicates an adverse prognosis in the setting of stable 
coronary artery disease.
4
 Elevated coronary microvascular resistance (MVR) is the hallmark of MVD. 
Two invasive indices of MVR are now described. Both derive MVR from simultaneous distal 
coronary artery measurements of pressure and flow during hyperemia using intra-coronary guidewires. 
However, the index of microcirculatory resistance (IMR) 
5
 estimates flow with thermodilution, 
whereas hyperemic microvascular resistance (hMR) measures Doppler-flow velocity.
6
 Both indices 




 regional wall motion 
7
 and adverse LV 
remodeling.
7
 However to date, no study has compared hMR and IMR against invasive and non-
invasive measurements of MVD in humans. Our study aims were to determine the level of agreement 
between IMR and hMR across a range of MVR and to compare the ability of IMR and hMR to predict 
independent invasive and non-invasive measures of MVD.  
Methods 
 In this prospective, two-centre study, patients undergoing coronary angiography were enrolled 
at St. Thomas Hospital, London, United Kingdom and the VU University Medical Centre, 
Amsterdam, The Netherlands. To sample a wide range of MVR, we enrolled two groups: those with 
stable angina and those presenting with an AMI, defined as a cardiac biomarker elevation in 
association with characteristic electrocardiographic (ECG) changes and/or typical symptoms. In AMI 
patients measurements were made in the infarct artery following PCI and in an angiographically 
normal reference artery when feasible. Exclusion criteria were hemodynamic instability or cardiogenic 
shock, significant LV dysfunction, previous coronary artery bypass grafting, severe comorbidity, left 
main stem disease, and standard contraindications to CMR. The protocols were approved by NRES 
London Westminster Medical Ethics Review Committee and the IRB of VU University Medical 
Centre in Amsterdam. All patients were asked to give written informed consent.  
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 Measurements were taken in coronary arteries without hemodynamically significant coronary 
artery disease (defined as fractional flow reserve (FFR) > 0.80), or immediately following successful 
PCI in patients with a significant coronary artery stenosis. After calibrating and normalising to aortic 
root pressure through a 6F-guiding catheter, a 0.014-inch dual pressure and Doppler flow-velocity 
tipped sensor guidewire (ComboWire Guidewire, Phillips Volcano, San Diego, USA) and a 0.014-
inch Pressure Wire® (with temperature thermistors on the distal shaft and tip: St Jude Medical, St. 
Paul, Minnesota, USA) were advanced to the distal vessel (>5cm from the coronary ostia). The 
pressure transducers of each wire were positioned adjacent to each other (Fig. 1B). The following 
measurements were taken after administration of intracoronary nitrates (200-300 mcg): aortic pressure 
(Pa), distal coronary artery pressure (Pd), Doppler-derived average peak velocity (APV) and 
thermodilution-derived transit mean time (Tmn). 
5, 9
 Measurements were taken at rest and during peak 
hyperemia with intravenous adenosine (140 mcg/kg/min). The following were then calculated as 








 and thermodilution-derived 
CFR,
9
 and in AMI patients corrected TIMI frame count.
13
 Doppler-flow velocity tracings of 
insufficient quality were discarded from analysis. CFR was then calculated as the average of Doppler-
derived CFR and thermodilution-derived CFR. Investigators performing data analyses were blinded to 
all clinical data. CMR scans were performed using either a 3-Tesla MR-scanner (St Thomas’ Hospital, 
London: Achieva, Phillips Healthcare, Best, Netherlands) or 1.5-Tesla MR-scanner (VU University 
Medical Centre, Amsterdam: Magnetom Avanto, Siemens, Erlangen, Germany). Cine images were 
acquired in 2-, 3-, and 4-chamber orientations and in a whole LV short-axis stack using a steady-state 
free precession sequence. CMR high-resolution stress (adenosine 140mcg/kg/min for 4 minutes) and 
rest perfusion scans were performed exclusively on a 3-Tesla MR-scanner, within 48 hours of MVR 
measurements, using gadolinium contrast. In AMI patients late gadolinium enhancement images were 
obtained 15 minutes following the last CMR contrast injection. Left ventricular (LV) ejection fraction 
and LV mass were calculated from cine images. The myocardial perfusion reserve index (MPRI) was 
derived from semi-quantitative perfusion analysis as previously described, to provide territory specific 
values to match invasive data, using a 16-segment American Heart Association model (Fig. 7 online 
data supplement).
14
 Microvascular obstruction was manually delineated from late gadolinium 
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enhancement images as an area of hypoenhancement within infarcted LV mass (Fig. 1D).
15
 Extensive 
MVO was a pre-defined dichotomous variable when there was > 2ml MVO volume present.
16
 Further 
details on the methods can be found in the online data supplement. 
 Statistical analyses were performed using GraphPad Prism 6.0 (GraphPad, San Diego, USA) 
and MedCalc Statistical Software version 12.7.8 (MedCalc Software, Ostend, Belgium). Continuous 
variables were tested for normality using the Shapiro–Wilk test and presented as mean ± SD when 
data were normally distributed or as median with interquartile range when data were non-normally 
distributed. Correlations between hMR and IMR, and each with CFR, MPRI and MVO were assessed 





 and extensive MVO.
16
 Receiver-operator characteristic (ROC) 
analysis was performed to determine the best cut-off values for predicting MVD using each method, 
and comparisons made using the DeLong method. P values of <0.05 were considered significant.  
Results  
 The flow of patients through the study is shown in Fig. 2. Two patients (4%) were excluded 
due to poor quality Doppler traces, leaving 54 patients (10 stable angina patients and 44 AMI patients: 
33 with STEMI; 11 with non-STEMI) with 74 complete invasive physiology datasets (Table 1). 
Invasive and CMR physiological data was acquired in 40 patients (Table 2: 8 stable angina patients 
and 32 AMI patients: 27 with STEMI; 5 with non-STEMI). The time between invasive measurements 
and CMR scans was 24 hours (7-49hours). In the enrolled population (see table 1), hMR was 2.60 
(1.99, 3.43) mmHg·cm
-1
·sec and IMR was 19.0 (13.0, 29.8) U. hMR significantly correlated with IMR 
(Fig. 3: rho=0.39; p=0.0006). Baseline and hyperemic thermodilution Tmn values were 0.56 (0.35, 
0.92) seconds and 0.27 (0.18, 0.39) seconds respectively. Baseline and hyperemic Doppler APV 
values were 15.3 (12.0, 20.7) cm
-1
.s and 29.4 (21.5, 37.6) cm
-1
.s respectively. Tmn values correlated 
significantly APV values at baseline (rho=-0.36; p=0.002) and hyperemia (rho=-0.41; p=0.0003). 
There was a strong correlation between Doppler-derived CFR 1.90 (1.46, 2.21) and thermodilution-
derived CFR 1.82 (1.50, 2.47) (rho=0.61; p<0.0001). 
 hMR and IMR correlated with CFR (hMR, rho=-0.52 p<0.0001; IMR, rho=-0.24 p=0.04). 
hMR values were higher in patients with MVD defined dichotomously by CFR (3.16 versus (vs.) 2.12 
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mmHg·cm
-1
·sec, p<0.0001: Fig. 6A), but there was no difference between groups using IMR (22 vs. 
19 U, p=0.25: Fig. 6A).  Delong ROCanalysis demonstrated that hMR had superior diagnostic 
accuracy compared with IMR at predicting MVD: area under curve (AUC) 0.82 vs. 0.58, p<0.001 
(Fig. 4). A threshold of ≥ 2.5 mmHg·cm-1·s for hMR provided the highest sensitivity (0.77) and 
specificity (0.77) for detecting MVD, while the optimal threshold for IMR was ≥ 21.5 U, with 
sensitivity of 0.51 and specificity of 0.71.  
 hMR was significantly correlated with MPRI (rho=-0.58; p<0.001) but IMR was not (rho=-
0.27; p=0.15). hMR and IMR values were higher in patients with MVD, defined dichotomously by 
MPRI (hMR: 3.43 vs. 2.11 mmHg·cm
-1
·sec, p<0.001, IMR: 27.0 vs. 18.4 U, p=0.02: Fig. 6B). ROC 
analysis showed hMR had numerically superior diagnostic accuracy over IMR to predict MPRI, 
although the difference did not reach statistical significance (AUC, 0.85 vs. 0.72, p=0.19) (Fig. 5 (A). 
A threshold of ≥ 2.5 mmHg·cm-1·s for hMR provided the optimal sensitivity (0.82) and specificity 
(0.80) for predicting MVD. The best cut off value for IMR was ≥ 24.0 U, with poorer sensitivity 
(0.64) and specificity (0.75).  
 In the AMI patients with invasive and CMR data (see Fig. 2), MVO was visible in 42% of 
patients. In these patients MVO volume was 3.2 mls (2.0, 5.2). Both infarct-related artery hMR and 
IMR measurements correlated with MVO volume (hMR, rho=0.46 p=0.001; IMR, rho=0.36 p=0.01). 
hMR and IMR values were both significantly higher when there was evidence of extensive MVO 
(hMR 3.74 vs. 2.60 mmHg·cm
-1
·sec, p=0.003; IMR 23.5 vs. 19.0 U, p=0.04: Fig. 6C). ROC analysis 
demonstrated that hMR had numerically superior diagnostic accuracy over IMR to predict the 
presence of extensive MVO (superior sensitivity), but this was not significant  (AUC 0.83 vs. 0.72, 
p=0.22) (Fig. 5 (B). A threshold of ≥ 3.25 mmHg·cm-1·s provided the highest sensitivity (0.78) and 
specificity (0.74) for detecting extensive MVO. The best cut off for IMR was ≥ 40 U with sensitivity 
(0.44) and specificity (0.91). In addition, hMR had superior diagnostic accuracy over IMR to predict 
the presence of any MVO, but this difference was not significant  (AUC 0.75 vs. 0.66).  
Discussion 
 To our knowledge, this is the first study in humans to have simultaneously assessed the 
correlation of two invasive indices of MVR, Doppler-derived hMR and thermodilution-derived IMR, 
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against each other and against independent measures of MVD. The main findings of this study are: (1) 
hMR and IMR correlate modestly with each other, and therefore cannot be considered equivalent 
predictors of MVD; (2) hMR had superior diagnostic accuracy over IMR to predict MVD determined 
invasively by CFR; (3) hMR had clinically superior sensitivity over IMR to predict MVD determined 
by cardiac magnetic resonance derived MPRI and extensive MVO, but there were no statistically 
significant differences observed; (4) an hMR threshold of ≥2.5 mmHg·cm-1·s and an IMR threshold 
between 21.5 and 24 U were optimal for predicting MVD determined by CFR and MPRI; (5) in the 
infarct related artery following an AMI, an hMR threshold of ≥ 3.25 mmHg·cm-1·s and an IMR 
threshold of ≥ 40 U were optimal for predicting MVD determined by extensive MVO.  
 Optimal assessment of MVD enables better risk stratification for adverse cardiovascular 
outcomes. In addition, in the setting of AMI post PPCI, instant MVR measurement could help select 
patients most likely to benefit from adjunctive pharmaco-therapy (e.g. intracoronary GpIIbIIIa 
inhibitors
19, 20
). Accurate assessment of MVR can be performed safely in the cardiac catheter 
laboratory, across a broad spectrum of MVD in AMI and stable angina patients, using either hMR or 
IMR. However, although equivalent hyperaemic distal pressures were obtained from the two 
intracoronary guidewires, overall correlation between hMR and IMR was far from strong (rho=0.39). 
Therefore discrepancies in the MVR measurements relate to differences in the estimation of flow. 
Each technique has inherent theoretical assumptions that are challenged in varying pathophysiological 
states. Thermodilution derived transit time is a surrogate of absolute coronary blood flow and is not 
indexed to the amount of myocardium subtended. Doppler flow velocity however decreases only by a 
fraction as branching occurs and therefore precise positioning within the distal vessel is less important 
as long as a good Doppler flow trace is obtained (~5 minutes).  





) and IMR (32 to 40
7, 21
), in patients who have suffered a recent AMI. The 
thresholds we identified for hMR and IMR to predict the presence of MVO are similar to that 
previously reported.
8, 16, 22
  The thresholds for predicting MVD with CFR and MPRI, which are more 
sensitive measures of MVD, are understandably lower for both hMR and IMR. Recently Patel et al 
measured hMR and IMR directly following PPCI in 34 patients recruited with ST-segment elevation 
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myocardial infarction.
23
 They demonstrated that hMR had a superiority trend over IMR in predicting 
parameters of infarct size and impaired left-ventricular ejection fraction, but this failed to reach 
statistical significance.
23
 However they did not include measurements of MVD in this comparison.  
 Several study limitations should be acknowledged. First, notwithstanding the detailed 
physiological characterization of our study cohort, this is a study with a relatively small sample size. 
Second, there is currently no true reference standard measurement of microvascular function. In our 
study we used multiple distinct modalities of assessing microvascular function, which we believe 
represents the best available composite clinical surrogate for a true reference standard. CFR was 
chosen as the invasive measurement of MVD because it was readily obtainable in every patient, and is 
utilized in clinical practice as a marker of MVD (with CFR<2.0 in unobstructed coronary arteries, as 
pre-specified in our study).
17
 A few investigators have used different CFR thresholds, namely 2.3 and 
2.5. In our study, the performance of hMR was better than IMR (when comparing AUC) with either of 
these CFR thresholds. Third, whilst we acknowledge that CFR can be affected by several 
hemodynamic factors and loading conditions, these conditions were minimized by ensuring that: a) 
baseline and peak measurements for Doppler and thermodilution were taken immediately after each 
other, b) all hyperemic measurements were taken during steady state hyperemia with intravenous 
adenosine and c) no other drugs or intravenous fluids were administered between Doppler and 
thermodilution measurements. Fourth, CMR late gadolinium enhancement was performed up to 6 days 
post AMI and therefore the measurements may be confounded by partial resolution of transient MVD 
post AMI. Nevertheless, this would be expected to affect both hMR and IMR to the same extent. 
Finally, it should be noted that there is no accepted dichotomous threshold for defining MPRI and 
MVO and the values we have used may differ from some studies. 
 This prospective two-centre study assessed the correlation between Doppler-derived 
hyperemic MVR and thermodilution-derived index of microcirculatory resistance: against each other, 
and against independent reference measures of MVD. We found these two invasive indices are both 
predictors of MVD. However, only modest correlation was found between hMR and IMR| Therefore 
they cannot be considered equivalent predictors of MVD.   
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Figure Legends:  
 
Fig. 1. Cardiac catheterization protocol used to derive invasive measurements of microvascular 
resistance.  
(A) Combomap Console (Volcano® Corporation, San Diego, USA) displaying continuous aortic 
and distal coronary artery pressure (Pd) and Doppler flow velocity.  
(B) Coronary angiographic image demonstrating a 0.014-in ComboWire (Volcano® Corporation, 
San Diego, USA) and a 0.014-in Pressure Wire® (St Jude Medical, Uppsala, Sweden) placed 
in equivalent positions in the distal circumflex artery.  
(C) St Jude Console (St Jude Medical, Uppsala, Sweden) displaying aortic and distal coronary 
artery pressure (Pd), and three transit mean time (Tmn) measurements at both baseline and 
during steady state hyperemia.  
(D) Late gadolinium enhancement cardiac magnetic resonance image 5 days after a revascularized 
acute ST-segment elevation myocardial infarction of the left anterior descending coronary 
artery. This short-axis view shows a hypo-enhanced core of microvascular obstruction (MVO) 
within a hyperenhanced area of infarcted tissue in the anteroseptal myocardium. 
 
Fig. 2. Flow of patients through the study. Two patients (4%) were excluded due to poor quality 
Doppler traces, leaving 54 patients (10 stable angina patients and 44 acute myocardial infarction 
(AMI) patients: 33 with STEMI; 11 with non-STEMI) with 74 complete invasive physiology datasets 
(Table 1: those with a full hyperemic microvascular resistance, index of microcirculatory resistance 
and coronary flow reserve dataset from at least one vessel). Invasive and cardiovascular magnetic 
resonance (CMR) physiological data was acquired in 40 patients (Table 2: 8 stable angina patients and 
32 AMI patients: 27 with STEMI; 5 with non-STEMI). 14 patients were excluded due to 
claustrophobia, patient preference (declined), being too obese to have a CMR scan (logistics), or due 
to poor quality perfusion data from an inadequate breath-hold. * = CMR infarct size and 
microvascular obstruction (MVO) measurements were obtained in all 32 AMI patients (27 with 
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STEMI; 5 with non-STEMI), whereas CMR perfusion was only performed on high-resolution 3-Tesla 
perfusion scans in 23 patients (8 stable angina patients and 15 AMI patients). 
 
Fig. 3. Correlation of hyperemic microvascular resistance (hMR) versus the index of microcirculatory 
resistance (IMR).  
 
Fig. 4. Performance of invasive indices of microvascular resistance versus an invasive standard of 
coronary microvascular dysfunction: receiver-operating characteristics analysis. Accuracy of 
hyperemic microvascular resistance (hMR) versus index of microcirculatory resistance (IMR) in 
predicting coronary flow reserve (CFR) < 2.0 in vessels with a fractional flow reserve of > 0.80. The 
optimal thresholds were ≥ 2.5 mmHg cm-1 s for hMR and ≥ 21.5 U for IMR. 
 
Fig. 5. Performance of invasive indices of microvascular resistance versus non-invasive markers of 
coronary microvascular dysfunction: receiver-operating characteristics analysis. (A) Accuracy of 
hyperemic microvascular resistance (hMR) and index of microcirculatory resistance (IMR) in 
predicting myocardial perfusion reserve index <1.0, a non-invasive marker of coronary microvascular 
dysfunction. The calculated cut off values were ≥ 2.5 mmHg cm-1 s for hMR and ≥ 25 U for IMR.  
(B) Accuracy of hMR and IMR in predicting the presence or absence of extensive microvascular 
obstruction (> 2mls),
20
 a non-invasive standard of coronary microvascular dysfunction in acute 
myocardial infarction. The best cut off values were ≥ 3.25 mmHg cm-1 s for hMR and ≥ 40 U for IMR.
Fig. 6. Hyperemic microvascular resistance (hMR) and index of microcirculatory resistance (IMR) 
invasively measured in patients with and without evidence of microvascular dysfunction: as evidenced 
by (A) invasive coronary flow reserve (CFR), (B) non-invasive myocardial perfusion reserve index 
(MPRI) and (C) non-invasive extensive microvascular obstruction (MVO). Boxes represent median 









percentile are presented as individual data point. 
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Table 1. Clinical Demographics and Angiographic Characteristics of the 54 Patients 




Men  40 (90) 9 (90) 
Age (years)  60.2 ± 10.6 61.7 ± 9.0 
Body Mass Index (kg/m
2) 
 26.9 ± 3.7 29.8 ± 3.4 
 Hypertension  29 (64) 7 (64) 
 Diabetes Mellitus  21 (47) 3 (27) 
 Hypercholesterolemia          36 (80)         9 (82) 
  Smoker  30 (67) 8 (73) 
Non-culprit/Non-treated Measurements    
 LAD / LC / Right  9 / 2 / 7 6 / 3 / 0 
 Fractional Flow Reserve  0.95 ± 0.06 0.89 ± 0.04 
Culprit/treated Measurements    
 LAD / LC / Right  24 / 7 / 10 3 / 0 / 3 
 Fractional Flow Reserve (post PCI)  0.93 ± 0.06 0.92 ± 0.05 
Acute Myocardial Infarction Characteristics    
 Corrected TIMI frame count  17 (10-26) n/a 
 Peak Troponin T, μg/L  1075 (203-7189) n/a 
 Data are number (%), mean±SD or median (IQR). LAD, left anterior descending; LC, left 
circumflex artery; PCI, percutaneous coronary intervention. 
Table 2. Cardiac Magnetic Resonance (CMR) Data 
Variable All patients 
Duration between invasive measurements and CMR, hours 24 (7, 49) 
Semi-quantitative CMR analysis (31 datasets from 23 patients*)  
 Myocardial Perfusion Reserve Index  1.07 (0.86, 1.49) 
Volumetric analysis (40 datasets from 40 patients)  
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 Left Ventricular End Diastolic Volume, ml 174 (150, 200) 
 Left Ventricular End Systolic Volume, ml 81 (55, 119) 
 Left Ventricular Ejection Fraction, % 52 (41, 63) 
Microvascular Obstruction (32 datasets from 32 patients)  
 Evidence of Microvascular Obstruction, number 13 
 Evidence of extensive** Microvascular Obstruction, number 10 
Quantitative infarct size analysis (32 datasets from 32 patients)  
 Infarct Size, g 22.5 (5.1, 35.2) 
 Infarct Size % of Left Ventricular mass 14.3 (4.5, 24.8) 
 Data are number, median (interquartile range) or mean ± SD. * = includes MPRI values from 
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Fig. 1 AJC hMR IMR_bestsetConverted.png 
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Fig. 2 AJC hMR IMR_bestsetConverted.png 
Page 20 of 26
  
 






Fig. 3 AJC hMR IMR_bestsetConverted.png 
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Fig. 4 AJC hMR IMR_bestsetConverted.png 
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Fig. 5 AJC hMR IMR_bestsetConverted.png 
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Fig. 6 AJC hMR IMR_bestsetConverted.png 
Page 25 of 26
  
 






Fig. S1 AJC hMR IMR.jpg 
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